Certified by Founder Lodge
Flashpoint Therapeutics
United States - Palo Alto, California
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Flashpoint Therapeutics is developing a new class of cancer immunotherapies through rational nanoscale design of therapeutic architecture to optimize anti-tumor immune response.
Across 9 i
Beta Lab
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Alchemyca Biotech | $2,500,000 | (Nov 22, 2024)
Shinami | $5,645,000 | (Nov 22, 2024)
Iontra Inc | $45,000,000 | (Nov 22, 2024)
Clean Skin Club | $32,000,000 | (Nov 22, 2024)
Lighthouse (UK) | $370,000,000 | (Nov 22, 2024)
